PVI
WVE icon

Pura Vida Investments’s Wave Life Sciences WVE Stock Holding History

Pura Vida Investments’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,886
Closed -$82K – 283
2022
Q1 		$82K Sell
40,886
-153,220
-79% -$375K ﹤0.01% 223
2021
Q4 		$609K Buy
+194,106
New +$806K 0.02% 206

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pura Vida Investments's WVE Position: Q2 2022 in Review

Pura Vida Investments sold out of Wave Life Sciences (WVE) in Q2 2022, closing a stake of 40,886 shares — an estimated $82K sold.

Pura Vida Investments first reported a position in WVE in Q4 2021 and held it in 2 quarters. The position peaked at $609K in Q4 2021. 60 funds tracked by Wall St. Rank hold WVE as of Q2 2022.

  • Pura Vida Investments reported no remaining Wave Life Sciences position as of Q2 2022 after selling out during the quarter.
  • Pura Vida Investments sold 40,886 Wave Life Sciences shares in Q2 2022, an estimated $82K.
  • Pura Vida Investments first reported a position in Wave Life Sciences in Q4 2021 and held it in 2 quarters.
  • Pura Vida Investments's Wave Life Sciences position peaked at $609K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2022.

Based on Pura Vida Investments's 13F filing for Q2 2022, filed 15 Aug 2022.